In this study, we combined low pH and cathepsin B dual-stimulus-triggered delivery carriers with a bioorthogonal reaction-activated prodrug to achieve regulated activation of the prodrug. A workable method for precise tumor therapy and imaging is provided by the bioorthogonal reaction, which activates the prodrug and fluorescent probe.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d3cc00177f | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!